机构地区:[1]成都市妇女儿童中心医院新生儿科,610091
出 处:《中华实用儿科临床杂志》2015年第2期114-117,共4页Chinese Journal of Applied Clinical Pediatrics
基 金:四川省卫生厅资助项目(090087)
摘 要:目的探讨西地那非(SIL)联合高频振荡通气(HFOV)治疗新生儿持续肺动脉高压(PPHN)的疗效及不良反应。方法2010年9月至2012年9月成都市妇女儿童中心医院89例PPHN患儿根据随机数字表随机分为HFOV组、常频机械通气(CMV)组、HFOV联合SIL组(HFOV+SIL组)及CMV联合SIL组(CMV+SIL组)。治疗前及治疗后3d分别进行动脉血气、肺动脉压以及不良反应的监测。治疗前后组间均数比较采用SNK组间多重比较法,组间率的比较采用,检验。结果治疗后CMV+SIL组、HFOV组以及HFOV+SIL组的动脉血氧分压[(79.1±13.7)mmHg(1mmHg=0.133kPa)、(77.9±14.6)mmHg、(85.4±15.2)mmHg]、动脉血氧饱和度[(87.8±13.4)%、(88.4±15.6)%、(96.1±15.9)%]、动脉血二氧化碳分压[(42.5±11.3)mmHg、(40.2±10.5)mmHg、(35.6±8.7)mmHg]以及肺动脉压[(31.1±8.1)mmHg、(30.4±9.5)mmHg、(25.8±7.3)mmHg]均较CMV组[(69.9±12.3)mmHg、(81.1±14.9)%、(48.1±9.5)mmHg、(35.6±8.9)mmHg]改善明显(F=4.6293、3.6732、5.8653、4.8495,P〈0.05),而HFOV+SIL组效果最为明显(P〈0.05),CMV+SIL组和HFOV组改善效果相同(P〉0.05)。HFOV+SIL组治疗有效率(90%)为4组最高(χ^2=7.938,P〈0.05)。治疗期间所有患儿未出现不良反应。结论SIL和HFOV联合使用治疗PPHN可能是一种更为有效和安全的方法。Objective To explore the effectiveness and adverse effect of high frequency oscillation ventilation (HFOV) combined with Sildenafil (SIL) treatment on newborns with persistent pulmonary hypertension ( PPHN ). Methods A total of 89 cases of PPHN infants collected from Chengdu Women and Children's Central Hospital from Sep. 2010 to Sep. 2012 were randomly divided into HFOV group, constant mechanical ventilation (CMV) group, HFOV combined SIL group ( HFOV + SIL group) and CMV combined with SIL group ( CMV + SIL group). The arterial blood gas, pulmonary artery pressure ( PAP ) and adverse reactions were monitored before and 3 days after treatment. SNK multiple comparison method andx2 test were performed for data before and after treatment among groups for continuous variables and categorical variables, respectively. Results The levels of Pa ( O2 ) [ (79. 1 ± 13.7 ) mmHg ( 1 mmHg = 0.133 kPa),(77.9±14.6) mmHg,(85.4±15.2) mmHg],Sa(O2) [(87.8±13.4)%,(88.4±15.6)%, (96.1±15.9)%],pa(CO2)[(42.5±11.3) mmHg,( 40.2±10.5) mmHg,(35.6±8.7) mmHg] and PAP [ (31.1±8.1) mmHg,(30.4 ±9.5) mmHg, (25.8±7.3) mmHg] were all improved significantly in CMV + SIL group,HFOV group and HFOV + SIL group compared with those in CMV group[ (69.9 ± 12.3) mmHg, (81. 1 ± 14. 9) %, ( 48.1 ±9.5 ) mmHg, (35.6 ± 8.9) mmHg ] ( F = 4. 629 3,3. 673 2,5. 865 3,4. 849 5, P 〈 0.05 ), espe- cially for HFOV + SIL group( P 〈 0.05 ). No significant difference in such indicators was observed between CMV + SIL group and HFOV group ( P 〉 0. 05 ). The effective rate in HFOV + SIL group ( 90% ) was the highest among the 4 groups (χ^2 = 7. 938,P 〈 0. 05 ). During the treatment, all neonates have no adverse reaction. Conclusion The com- bined use of SIL and HFOV might be a more effective and safer method in the treatment of PPHN of neonate.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...